Nantucket could employ GM mice to fight Lyme disease

JZPRQHERRHGRKH RHHXZ LRZPLYL LKRYZXRFZIROZIRQHIZLH ZTL RALPRALPRDLIZVLYLELZZ

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

Nantucket boasts some of the highest Lyme infection rates in the country, and a new plan would involve modifying the genes of tens of thousands of mice to keep them from spreading the Lyme bacterium to ticks, which in turn infect people.

Any release is years away, but an MIT professor presented the idea to the Nantucket board of health and an audience of about 20 residents and scientists, who were broadly favorable.

If the project is realized, it might be the first release into the wild of animals modified with the cutting-edge gene-editing technique CRISPR. Other types of gene editing have been used, for instance, to make farmed salmon grow faster and to make disease-carrying mosquitoes unable to reproduce.

“This is something new,” said Kevin Esvelt, assistant professor at the MIT Media Lab and the project’s organizer. “We are considering deliberate alteration of the local environment.”

Read full, original post: To halt the spread of Lyme, Nantucket residents consider genetically engineered mice

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
ChatGPT-Image-May-13-2026-11_56_08-AM
After slashing global health aid by $19 Billion, Trump moves to tap $2.1 billion more—to cover shutdown costs
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?
ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Screenshot-2026-05-12-at-9.58.31-PM
'He seems fine': Marty Makary out as FDA commissioner
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
Screenshot-2026-05-11-104424
Hantavirus outbreak research: Trump administration shut down study last year on rodent-to-human transmission
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
images
The never-ending GMO debate: Pros and cons
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.